Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 87808327 |
Registration Number | 5927361 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Daniel Frohling, |
Attorney Docket Number | 210336-00017 |
Law Office Assigned | M50 |
Employee Name | FREEMAN, BREANNA SHALE |
2018-02-23 | Application Filed |
2018-12-19 | Location: PUBLICATION AND ISSUE SECTION |
2018-12-19 | Status: Live/Pending |
2019-01-02 | Transaction Date |
2019-01-22 | Published for Opposition |
2019-12-03 | Trademark Registered |
Owner: | ![]() |
Entity Statement | limited company (ltd.) |
Address | Ardmore, Diamond Road Crumlin, County An GB BT294QY GB5 |
Legal Entity Type | |
Legal Entity State | GB |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 9 |
U.S. Codes: | 021,023,026,036,038 |
International Codes: | 10 |
U.S. Codes: | 026,039,044 |
Type Code | Type |
---|---|
GS0101 | medical apparatus and instruments for medical use, namely, for use in vitro diagnostic testing procedures to detect and diagnose drug residues used in immunoassay procedures and for use in measuring blood proteins, antibodies, enzymes, immunoglobulins and hormones; diagnostic apparatus and instruments for medical use, namely, for use in vitro diagnostic testing procedures to detect and diagnose drug residues used in immunoassay procedures and for use in measuring blood proteins, antibodies, enzymes, immunoglobulins, hormones and drugs; diagnostic imaging apparatus for medical use, namely, electromechanical diagnostic analyser utilizing a chemiluminescent detection system for use in in vitro diagnostic testing procedures and for use in measuring blood proteins, antibodies, enzymes, immunoglobulins, hormones and drugs; medical diagnostic testing apparatus and instruments for use in immunoassay procedures, namely, for use in the measurement of antibodies, immunoglobulins, hormones and drugs representing various drug classes; light detectors for use in vitro diagnostic testing procedures, namely, a chemiluminescence detection system for medical purposes |
GS0011 | Diagnostic preparations for scientific purposes; chemical reagents for scientific or medical research and for use in the analysis of food products; enzymes for use in scientific and medical research applications; protein arrays for use in scientific and medical research applications; diagnostic preparations for analysis of food products and water for scientific or research use; clinical diagnostic preparations for clinical or medical laboratory use; clinical diagnostic reagents for in vitro use for clinical or medical laboratory use; chemical reagents other than for medical or veterinary purpose, namely, chemical reagents for detection and monitoring of disease states in vitro; diagnostic proteins, namely, protein arrays for scientific and medical research featuring antibodies and antigens used for monitoring of disease states in vitro |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2018-02-27 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-03-01 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2018-06-08 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2018-06-19 | 4 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2018-06-19 | 5 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-06-19 | 6 GNRN O:Outgoing Correspondence |
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 2018-08-31 | 7 EWAF I:Incoming Correspondence |
ASSIGNED TO LIE | 2018-09-12 | 8 ALIE A:Allowance for Publication |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2018-09-13 | 9 CHAN I:Incoming Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-12-10 | 10 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-12-10 | 11 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-12-10 | 12 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-12-18 | 13 CNSA P: |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-01-02 | 14 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2019-01-22 | 15 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-01-22 | 16 NPUB E:E-Mail |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-03-19 | 17 NOAM E:E-Mail |
TEAS STATEMENT OF USE RECEIVED | 2019-09-16 | 18 EISU I:Incoming Correspondence |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2019-10-05 | 19 AITU A:Allowance for Publication |
USE AMENDMENT FILED | 2019-09-16 | 20 IUAF S: |
STATEMENT OF USE PROCESSING COMPLETE | 2019-10-05 | 21 SUPC I:Incoming Correspondence |
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2019-10-31 | 22 CNPR P: |
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2019-11-01 | 23 SUNA E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2019-12-03 | 24 R.PR A:Allowance for Publication |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.